On 12 October 2024, EFCCA organised a conference during UEG Week (Vienna) titled: "How can patients play a crucial role in medicines-related decision-making? An open dialogue with stakeholders and the presentation of the EFCCA...
We’re excited to present the latest issue of the EFCCA Magazine, now with a refreshed design! Inside, you’ll find an exclusive interview with Professor James Lee, who shares insights on his groundbreaking research into the causes...
EFCCA is excited to introduce a series of webinars, workshops and initiatives to be launched after the summer break.
Read the exclusive interview with Dr. James Lee, whose revolutionary research into a major cause of Inflammatory Bowel Disease (IBD) has been published in the Nature journal. ...
We are pleased to announce the release of two significant reports that highlight our continuous efforts and achievements in advocating for improved IBD care and quality of life worldwide.
This year the central theme for World IBD Day is "IBD Has No Borders", emphasising the global nature of IBD and the need for collective action. ...
From 7 to 9 June 2024, Brussels hosted the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) General Assembly, representing a significant event for our organisation....
EFCCA organised the conference "IBD Dialogues: Building Generations" held on 22 February at the ECCO'24 Congress in Stockholm presenting the preliminary results of our study on people with IBD aged...
We’re excited to share our latest edition of the EFCCA Magazine! Discover how EFCCA and its members are making a difference locally and globally, from raising IBD awareness through impactful campaigns advocating for improved...
There is very little scientific evidence on patient preference targeted at the IBD patient community.